Video

Stewart Tepper, MD

Publish date: May 11, 2015

At the 67th Annual Meeting of the American Academy of Neurology, Dr. Stewart Tepper discusses results from the COMPASS trial, a comparative effectiveness trial of intranasal delivery of low-dose sumatriptan for migraine relief.

 

References


The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

Headache Care Has Become More Costly and Less Effective
MDedge Neurology
Will Neuromodulation Change the Paradigm of Headache Treatment?
MDedge Neurology
Are Triptans Safe to Take in Pregnancy?
MDedge Neurology
Is Glutamatergic Modulation Effective Against Migraine?
MDedge Neurology
What Are the Neuropsychologic Effects of Cluster Headache?
MDedge Neurology
Postural Tachycardia Syndrome Is Common Among Migraineurs
MDedge Neurology
Updated Guideline for Acute Migraine Treatment
MDedge Neurology
Adult Migraineurs Have Atypical Correlations Between Cortical Thickness and Pain Thresholds
MDedge Neurology
Retired NFL Players Have Increased Incidence of Headache
MDedge Neurology
Robert Cowan, MD
MDedge Neurology

Related Articles